Providing pharmacological access to the brain: alternate approaches
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
San Diego u.a.
Acad. Press
1994
|
| Schriftenreihe: | Methods in neurosciences
21 |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | XVIII, 508 S. Ill., graph. Darst. |
| ISBN: | 0121852911 |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV009934662 | ||
| 003 | DE-604 | ||
| 005 | 20210707 | ||
| 007 | t | ||
| 008 | 941206s1994 ad|| |||| 00||| engod | ||
| 020 | |a 0121852911 |9 0-12-185291-1 | ||
| 035 | |a (OCoLC)31200653 | ||
| 035 | |a (DE-599)BVBBV009934662 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 |a DE-578 | ||
| 050 | 0 | |a QP356.3 | |
| 082 | 0 | |a 615.78 |2 20 | |
| 084 | |a WW 2200 |0 (DE-625)158906:13423 |2 rvk | ||
| 245 | 1 | 0 | |a Providing pharmacological access to the brain |b alternate approaches |c ed. by Thomas R. Flanagan ... |
| 264 | 1 | |a San Diego u.a. |b Acad. Press |c 1994 | |
| 300 | |a XVIII, 508 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Methods in neurosciences |v 21 | |
| 650 | 4 | |a Blood-Brain Barrier | |
| 650 | 4 | |a Blood-brain barrier | |
| 650 | 4 | |a Brain Diseases |x drug therapy | |
| 650 | 4 | |a Cell Transplantation | |
| 650 | 4 | |a Drug Delivery Systems |x methods | |
| 650 | 4 | |a Neurobiology | |
| 650 | 0 | 7 | |a Gehirn |0 (DE-588)4019752-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Methode |0 (DE-588)4038971-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmakologie |0 (DE-588)4045687-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Zentralnervensystem |0 (DE-588)4067637-7 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Zentralnervensystem |0 (DE-588)4067637-7 |D s |
| 689 | 0 | 1 | |a Pharmakologie |0 (DE-588)4045687-0 |D s |
| 689 | 0 | 2 | |a Methode |0 (DE-588)4038971-6 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Gehirn |0 (DE-588)4019752-9 |D s |
| 689 | 1 | 1 | |a Pharmakologie |0 (DE-588)4045687-0 |D s |
| 689 | 1 | 2 | |a Methode |0 (DE-588)4038971-6 |D s |
| 689 | 1 | |5 DE-604 | |
| 700 | 1 | |a Flanagan, Thomas R. |d 1951- |e Sonstige |0 (DE-588)1236669045 |4 oth | |
| 830 | 0 | |a Methods in neurosciences |v 21 |w (DE-604)BV004664735 |9 21 | |
| 856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006582003&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-006582003 | ||
Datensatz im Suchindex
| _version_ | 1804124301942587392 |
|---|---|
| adam_text | METHODS IN NEUROSCIENCES VOLUME 21 PROVIDING PHARMACOLOGICAL ACCESS TO
THE BRAIN: ALTERNATE APPROACHES EDITED BY THOMAS R. FLANAGAN CHATHAM
ASSOCIATES BARRINGTON, RHODE ISLAND DWAINE F. EMERICH SHELLEY R. WINN
CYTOTHERAPEUTICS PROVIDENCE, RHODE ISLAND ACADEMIC PRESS SAN DIEGO NEW
YORK BOSTON LONDON SYDNEY TOKYO TORONTO TABLE OF CONTENTS CONTRIBUTORS
TO VOLUME 21 IX PREFACE XV VOLUMES IN SERIES XVII SECTION I
CHARACTERIZING THE BLOOD-BRAIN BARRIER 1. CELLULAR RESPONSE OF CENTRAL
NERVOUS SYSTEM TISSUE TO INVASIVE THERAPEUTIC MEASURES 3 ANN LOGAN AND
MARTIN BERRY 2. MODELS OF ANGIOGENESIS AND THE BLOOD-BRAIN BARRIER 20
JEFFREY M. ROSENSTEIN AND JANETTE M. KRUM SECTION II TRANSIENTLY
REMOVING THE BLOOD-BRAIN BARRIER 3. OSMOTIC OPENING OF THE BLOOD-BRAIN
BARRIER AND BRAIN TUMOR CHEMOTHERAPY 35 PETER J. ROBINSON 4. OSMOTIC
BLOOD-BRAIN BARRIER MODIFICATION: INCREASING DELIVERY OF DIAGNOSTIC AND
THERAPEUTIC AGENTS TO THE BRAIN 52 EDWARD A. NEUWELT AND ROBERT A. KROLL
SECTION III FACILITATED TRANSPORT THROUGH THE BLOOD-BRAIN BARRIER 5.
PERIPHERAL ADMINISTRATION OF NERVE GROWTH FACTOR CONJUGATED TO AN
ANTI-TRANSFERRIN RECEPTOR ANTIBODY INCREASES CHOLINERGIC NEURON SURVIVAL
IN INTRAOCULAR FOREBRAIN TRANSPLANTS 71 ANN-CHARLOTTE GRANHOLM, PAUL T.
BIDDLE, CRISTINA BDCKMAN, TED EBENDAL, GREG GERHARDT, BARRY HOFFER,
LUDMILA MACKERLOVA, LARS OLSON, STINE SODERSTROM, LEE WALUS, AND PHILLIP
FRIDEN 6. FERROTRANSFERRIN AND ANTIBODY AGAINST THE TRANSFERRIN RECEPTOR
AS POTENTIAL VEHICLES FOR DRUG DELIVERY ACROSS THE MAMMALIAN BLOOD-BRAIN
BARRIER INTO THE CENTRAL NERVOUS SYSTEM 93 RICHARD D. BROADWELL, BELINDA
J. BAKER, WILLIAM A. BANKS, PHILLIP FRIDEN, MAJORIE MORAN, CONSTANCE
OLIVER, AND JUAN C. VILLEGAS VI TABLE OF CONTENTS 7. DEPOFOAM-MEDIATED
DRUG DELIVERY INTO CEREBROSPINAL FLUID 118 SINIL KIM SECTION IV
POLYMERIC RELEASE SYSTEMS FOR THE CENTRAL NERVOUS SYSTEM 8. INTERSTITIAL
DRUG DELIVERY TO THE CENTRAL NERVOUS SYSTEM USING CONTROLLED RELEASE
POLYMERS: CHEMOTHERAPY FOR BRAIN TUMORS 135 RAFAEL J. TAMARGO, ROBERT
LANGER, AND HENRY BREM 9. SUSTAINED INTRACEREBRAL DELIVERY OF NERVE
GROWTH FACTOR WITH BIODEGRADABLE POLYMER MICROSPHERES 150 ALEJANDRO
MENDEZ, PAUL J. CAMARATA, RAJ SURYANARAYANAN, AND TIMOTHY J. EBNER 10.
POLYMERIC DRUG CARRIER SYSTEMS IN THE BRAIN 169 ABRAHAM J. DOMB AND
ISRAEL RINGEL SECTION V USING PUMP DELIVERY DEVICES WITHIN THE BRAIN 11.
USING OSMOTIC MINIPUMPS FOR INTRACRANIAL DELIVERY OF AMINO ACIDS AND
PEPTIDES 187 JEFFREY D. WHITE AND MICHAEL W. SCHWARTZ 12. CONTINUOUS
CENTRAL NERVOUS SYSTEM INFUSION WITH ALZET OSMOTIC PUMPS 201 THEO HAGG
13. INJECTION OF BIOLOGICALLY ACTIVE SUBSTANCES INTO THE BRAIN 214 PAUL
M. CARVEY, TERRENCE J. MAAG, AND DONGHUI LIN SECTION VI USING IMPLANTED
LIVING TISSUES WITHIN THE BRAIN 14. FACTORS IMPORTANT IN THE SURVIVAL OF
DOPAMINE NEURONS IN INTRACEREBRAL GRAFTS OF EMBRYONIC SUBSTANTIA NIGRA
237 ROGER BARKER, ROSEMARY FRICKER, AND STEVEN B. DUNNETT 15. TECHNIQUES
IN ADRENAL MEDULLARY TRANSPLANTATION FOR EXPERIMENTAL NONHUMAN PRIMATE
PARKINSONISM 253 MASSIMO S. FIANDACA AND JEFFREY H. KORDOWER 16.
TECHNICAL ASPECTS OF TRANSPLANTATION OF THE ADRENAL MEDULLA TO THE
CAUDATE NUCLEUS AS A TREATMENT FOR PARKINSON S DISEASE 272 STEPHEN W.
CARMICHAEL, SUSAN L. STODDARD, AND PATRICK J. KELLY TABLE OF CONTENTS
VLL SECTION VII CREATING CELL LINES FOR TRANSPLANT THERAPIES 17.
TRANSPLANTATION OF EPIDERMAL GROWTH FACTOR-RESPONSIVE NEURAL STEM CELL
PROGENY INTO THE MURINE CENTRAL NERVOUS SYSTEM 281 JOSEPH P. HAMMANG,
BRENT A. REYNOLDS, SAMUEL WEISS, ALBEE MESSING, AND IAN D. DUNCAN 18.
APPLICATION OF ASTROCYTE TRANSPLANTS AS A THERAPEUTIC INTERVENTION 294
J. PATRICK KESSLAK AND RICHARD J. BRIDGES 19. DEVELOPMENT OF
IMMORTALIZED CELL LINES FOR TRANSPLANTATION IN CENTRAL NERVOUS SYSTEM
INJURY AND DEGENERATION MODELS 308 M. GIORDANO, H. TAKASHIMA, M.
POLTORAK, H. M. GELLER, AND W. J. FREED SECTION VIII USING IMPLANTED
LIVING CELLS WITHIN THE CENTRAL NERVOUS SYSTEM 20. USE OF GENETICALLY
MODIFIED CELLS TO DELIVER NEUROTROPHIC FACTORS AND NEUROTRANSMITTERS TO
THE BRAIN 329 LISA J. FISHER, GORDON R. CHALMERS, AND FRED H. GAGE 21.
NEUROPEPTIDE AND CATECHOLAMINE DELIVERY TO THE CENTRAL NERVOUS SYSTEM BY
IMPLANTED CHROMAFFIN CELLS 348 JACQUELINE SAGEN, JOHN D. ORTEGA, AND
GEORGE D. PAPPAS SECTION IX USING IMPLANTED ENCAPSULATED CELLS WITHIN
THE BRAIN 22. MICROENCAPSULATION OF CELLS IN THERMOPLASTIC COPOLYMER
(HYDROXYETHYL METHACRYLATE-METHYL METHACRYLATE) 371 M. V. SEFTON, H.
ULUDAG, J. BABENSEE, T. ROBERTS, V. HORVATH, AND U. DE BONI 23. HYDROGEL
APPLICATIONS FOR ENCAPSULATED CELLULAR TRANSPLANTS 387 SHELLEY R. WINN
AND PATRICK A. TRESCO 24. TEST FOR VALIDATING THE SAFETY OF ENCAPSULATED
XENOGRAFTS 403 T. R. FLANAGAN, B. FRYDEL, B. TENTE, M. LAVOIE, E.
DOHERTY, D. REIN, D. F. EMERICH, AND S. R. WINN VUL TABLE OF CONTENTS
SECTION X INDUCED GENE EXPRESSION IN INTRINSIC CENTRAL NERVOUS SYSTEM
CELLS WITH DNA INJECTED INTO THE BRAIN 25. PARTICLE BOMBARDMENT FOR GENE
TRANSFER INTO NERVE CELL SYSTEMS . 427 NING-SUN YANG, SHOUSHU JIAO, AND
CAROLYN DE LUNA SECTION XI VIRAL TRANSFECTION OF INTRINSIC CELLS WITHIN
THE BRAIN 26. A DEFECTIVE HERPES SIMPLEX VIRUS VECTOR SYSTEM FOR GENETIC
INTERVENTION IN THE ADULT BRAIN: APPLICATIONS TO GENE THERAPY AND
NEURONAL PHYSIOLOGY 443 ALFRED I. GELLER, MATHEW J. DURING, AND RACHAEL
NEVE 27. EXPRESSION OF NEUROTROPIC FACTOR GENES FROM HERPES SIMPLEX
VIRUS TYPE 1 VECTORS: MODIFYING NEURONAL PHENOTYPE 462 MICHAEL D.
GESCHWIND, BING LU, AND HOWARD FEDEROFF SECTION XII PREDICTING THE
FUTURE OF CENTRAL NERVOUS SYSTEM DELIVERY SYSTEM TECHNOLOGIES 28.
ASSESSING THE COMMERCIAL POTENTIAL OF CENTRAL NERVOUS SYSTEM DELIVERY
APPROACHES 485 JOHN S. SWEN, THOMAS R. FLANAGAN, AND THOMAS G. WIGGANS
INDEX 499
|
| any_adam_object | 1 |
| author_GND | (DE-588)1236669045 |
| building | Verbundindex |
| bvnumber | BV009934662 |
| callnumber-first | Q - Science |
| callnumber-label | QP356 |
| callnumber-raw | QP356.3 |
| callnumber-search | QP356.3 |
| callnumber-sort | QP 3356.3 |
| callnumber-subject | QP - Physiology |
| classification_rvk | WW 2200 |
| ctrlnum | (OCoLC)31200653 (DE-599)BVBBV009934662 |
| dewey-full | 615.78 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615.78 |
| dewey-search | 615.78 |
| dewey-sort | 3615.78 |
| dewey-tens | 610 - Medicine and health |
| discipline | Biologie Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02089nam a2200541 cb4500</leader><controlfield tag="001">BV009934662</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20210707 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">941206s1994 ad|| |||| 00||| engod</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0121852911</subfield><subfield code="9">0-12-185291-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)31200653</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV009934662</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-578</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">QP356.3</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.78</subfield><subfield code="2">20</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">WW 2200</subfield><subfield code="0">(DE-625)158906:13423</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Providing pharmacological access to the brain</subfield><subfield code="b">alternate approaches</subfield><subfield code="c">ed. by Thomas R. Flanagan ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">San Diego u.a.</subfield><subfield code="b">Acad. Press</subfield><subfield code="c">1994</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XVIII, 508 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Methods in neurosciences</subfield><subfield code="v">21</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Blood-Brain Barrier</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Blood-brain barrier</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Brain Diseases</subfield><subfield code="x">drug therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cell Transplantation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Delivery Systems</subfield><subfield code="x">methods</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neurobiology</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Gehirn</subfield><subfield code="0">(DE-588)4019752-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Methode</subfield><subfield code="0">(DE-588)4038971-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Zentralnervensystem</subfield><subfield code="0">(DE-588)4067637-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Zentralnervensystem</subfield><subfield code="0">(DE-588)4067637-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Methode</subfield><subfield code="0">(DE-588)4038971-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Gehirn</subfield><subfield code="0">(DE-588)4019752-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Methode</subfield><subfield code="0">(DE-588)4038971-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Flanagan, Thomas R.</subfield><subfield code="d">1951-</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)1236669045</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Methods in neurosciences</subfield><subfield code="v">21</subfield><subfield code="w">(DE-604)BV004664735</subfield><subfield code="9">21</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006582003&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-006582003</subfield></datafield></record></collection> |
| id | DE-604.BV009934662 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T17:43:30Z |
| institution | BVB |
| isbn | 0121852911 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-006582003 |
| oclc_num | 31200653 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR DE-578 |
| owner_facet | DE-355 DE-BY-UBR DE-578 |
| physical | XVIII, 508 S. Ill., graph. Darst. |
| publishDate | 1994 |
| publishDateSearch | 1994 |
| publishDateSort | 1994 |
| publisher | Acad. Press |
| record_format | marc |
| series | Methods in neurosciences |
| series2 | Methods in neurosciences |
| spelling | Providing pharmacological access to the brain alternate approaches ed. by Thomas R. Flanagan ... San Diego u.a. Acad. Press 1994 XVIII, 508 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Methods in neurosciences 21 Blood-Brain Barrier Blood-brain barrier Brain Diseases drug therapy Cell Transplantation Drug Delivery Systems methods Neurobiology Gehirn (DE-588)4019752-9 gnd rswk-swf Methode (DE-588)4038971-6 gnd rswk-swf Pharmakologie (DE-588)4045687-0 gnd rswk-swf Zentralnervensystem (DE-588)4067637-7 gnd rswk-swf Zentralnervensystem (DE-588)4067637-7 s Pharmakologie (DE-588)4045687-0 s Methode (DE-588)4038971-6 s DE-604 Gehirn (DE-588)4019752-9 s Flanagan, Thomas R. 1951- Sonstige (DE-588)1236669045 oth Methods in neurosciences 21 (DE-604)BV004664735 21 GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006582003&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Providing pharmacological access to the brain alternate approaches Methods in neurosciences Blood-Brain Barrier Blood-brain barrier Brain Diseases drug therapy Cell Transplantation Drug Delivery Systems methods Neurobiology Gehirn (DE-588)4019752-9 gnd Methode (DE-588)4038971-6 gnd Pharmakologie (DE-588)4045687-0 gnd Zentralnervensystem (DE-588)4067637-7 gnd |
| subject_GND | (DE-588)4019752-9 (DE-588)4038971-6 (DE-588)4045687-0 (DE-588)4067637-7 |
| title | Providing pharmacological access to the brain alternate approaches |
| title_auth | Providing pharmacological access to the brain alternate approaches |
| title_exact_search | Providing pharmacological access to the brain alternate approaches |
| title_full | Providing pharmacological access to the brain alternate approaches ed. by Thomas R. Flanagan ... |
| title_fullStr | Providing pharmacological access to the brain alternate approaches ed. by Thomas R. Flanagan ... |
| title_full_unstemmed | Providing pharmacological access to the brain alternate approaches ed. by Thomas R. Flanagan ... |
| title_short | Providing pharmacological access to the brain |
| title_sort | providing pharmacological access to the brain alternate approaches |
| title_sub | alternate approaches |
| topic | Blood-Brain Barrier Blood-brain barrier Brain Diseases drug therapy Cell Transplantation Drug Delivery Systems methods Neurobiology Gehirn (DE-588)4019752-9 gnd Methode (DE-588)4038971-6 gnd Pharmakologie (DE-588)4045687-0 gnd Zentralnervensystem (DE-588)4067637-7 gnd |
| topic_facet | Blood-Brain Barrier Blood-brain barrier Brain Diseases drug therapy Cell Transplantation Drug Delivery Systems methods Neurobiology Gehirn Methode Pharmakologie Zentralnervensystem |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006582003&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV004664735 |
| work_keys_str_mv | AT flanaganthomasr providingpharmacologicalaccesstothebrainalternateapproaches |